87°

Topics

ING Group
An early gain fades on Wall Street
An early gain fades on Wall Street

An early surge on the stock market evaporated Friday, as health care stocks tugged major indexes down. Biotech companies were especially hard-hit after U.S. lawmakers questioned the pricing of a Hepatitis C drug made by Gilead Sciences. The Standard & Poor's 500 index raced past an all-time high in early trading, then lost steam in the afternoon. It still finished with a solid weekly gain, up 1.4 percent. It might sound surprising that the stock market is trading near an all-time high with all the uncertainty surrounding China's slowing growth and simmering tensions between Russia and the West. Last week, those concerns were credited with knocking the S&P 500 index...

Loading